VistaGen Therapeutics Inc (VTGN) - Kompaniyaning sof foydasi

Vistagen Therapeutics (VTGN) korporativ emblemasi va logotipi

FDA ning yuqori kirish to'sig'i va ferinlar uchun patent himoyasi Vistagen Therapeutics (VTGN) kompaniyasining bozor holatini belgilaydi. Kompaniyaning sof pul oqimi joriy barqarorlikni namoyish etmoqda, bunda joriy daraja -0.07 ga tengdir. Burun orqali yuboriladigan antidepressantlar ishlab chiqilishi noyob xemosensor mexanizmlarga tayanadi, yakuniy bosqichdagi klinik sinovlarning muvaffaqiyati va M&A salohiyati esa kuchli o'sish drayverlarini yaratadi.

VTGN Vistagen Therapeutics Kompaniyaning sof foydasi (04.07.2022 - 01.11.2026)

vistagen.com (VTGN) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Vistagen|VTGN - Konsensus maqsadli narx
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati VTGN|VTGN - Korxona qiymati
- balans kapitallashuvi ko'rsatkichlari:
Aksiya hisobiga sof aktivlar Vistagen|VTGN - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor kapitallashuvi vistagen.com|VTGN - Kompaniyaning yakuniy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Jamlagan qarzning kapitalga nisbati Vistagen Therapeutics|VTGN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Vistagen|VTGN - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati VTGN|VTGN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Vistagen|Shoshilinch likvidlik koeffitsiyenti vistagen.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
VTGN - Sof daromad
Fundamental baholash:VTGN (VistaGen Therapeutics Inc)
vistagen.com yetakchi tovari

Vistagen Therapeutics kompaniyasining foydasi moliyaviy kirimlar va bozor kotirovkalari sintezi orqali aktivning narxlash samaradorligini real vaqt rejimida aks ettiruvchi operatsion daromadning dinamik oqimini ifodalaydi. Vistagen Therapeutics foyda grafigini tahlil qilish orqali investor klinik sinovlar xarajatlari bilan bog'liq kapital sarflash darajasini va ikkilamchi takliflar orqali muntazam ravishda mablag' yig'ish zaruriyatini baholashi mumkin.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Sof daromad NBIX|Kompaniyaning sof foydasi RGC|Sof foyda AXSM|Sof moliyaviy natija ACADIA Pharma|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|Sof moliyaviy natija Viking Therapeutics Corp (VKTX)|SUPN: Sof daromad|catalystpharma.com - Soliqlar to‘langandan keyingi foyda|DNLI: Sof foyda|Harmony Biosciences Inc (HRMY) - Sof foyda|BHVN (Biohaven Pharmaceutical) - Sof foyda|AMLX - Yillik sof foyda|Sof foyda TRVI|PRAX - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Anavex Life Sciences Corp. AVXL|CBLL: Kompaniya foydasi|PRTA: Sof daromad|Yakuniy foyda ALEC (Alector, Inc.)|ANNX (Annexon, Inc.) - Sof daromad|OMER: Soliqlar to‘langandan keyingi foyda|NGNE (Neurogene) - Sof foyda|ACIU: Yakuniy foyda|Sof foyda VYGR|NMRA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Scilex Holding Company SCLX|Yakuniy foyda TVGN|Alpha Cognition Corp - Sof foyda|CGTX - Sof foyda|Inhibikase (IKT) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda SAVA (Cassava Pharma)|ASRT (Assertio Holdings) - Sof foyda|Kompaniyaning sof daromadi Coya COYA|Sof daromad OVID (Ovid Therapeutics Inc.)|Sof foyda Acumen Pharmaceuticals Inc. (ABOS)|CervoMed Inc - Sof daromad|Soliqlar to‘langandan keyingi foyda ATHE (Alterity Therapeutics Ltd.)|Clene Nanomedicine - Sof foyda|Sof moliyaviy natija PepGen Inc. PEPG|JUNS: Sof foyda|Sof daromad Relmada Therapeutics Inc|Kompaniyaning sof foydasi Annovis Bio Corp|Grace Tx (GRCE) - Sof moliyaviy natija|Sof daromad AIFF (Firefly Neuroscience, Inc)|Kompaniyaning sof foydasi KLTO (anewmeds.com)|NeuroSense Therapeutics Ltd. - Sof daromad|Soliqlar to‘langandan keyingi foyda RVPH (Reviva Pharmaceuticals Holdings Inc.)|MetaVia, Inc. - Sof foyda|Yillik sof foyda NeurAxis Inc (NRXS)|heliusmedical.com (HSDT) - Kompaniyaning sof foydasi|Kompaniya foydasi PASG|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|Kompaniya foydasi NERV (Minerva Neurosciences Inc)|Sof foyda ATHA|ADXN - Kompaniyaning sof daromadi|Alzamend Neuro - Sof daromad|Sof foyda Cyclerion Therapeutics Inc. CYCN|PTIX - Kompaniyaning sof foydasi|Yakuniy foyda KTTA (Pasithea Therapeutics)|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Avenue Therapeutics Inc (ATXI)|Sof daromad BCLI|Kompaniyaning sof foydasi CARA|Sof foyda CHRO|Sof moliyaviy natija eliemtx.com|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|Sof moliyaviy natija Longboard (LBPH)|MRNS: Sof daromad|nkgenbiotech.com - Soliqlar to‘langandan keyingi foyda|NRBO: Sof foyda|Sage Therapeutics Inc. (SAGE) - Sof foyda|SNPX (Neurotrope) - Sof foyda|TRVN - Yillik sof foyda|Sof foyda VIGL|WENA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Cerevel Therapeutics, Inc. CERE